Marathon Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$995K Buy
11,534
+177
+2% +$15.6K 0.2% 77
2026
Q2
$888K Buy
11,357
+8,543
+304% +$689K 0.18% 83
2026
Q1
$244K Buy
2,814
+100
+4% +$9.6K 0.05% 148
2025
Q4
$261K Buy
+2,714
New +$264K 0.06% 140
2016
Q2
– Sell
-3,178
Closed -$238K – 90
2016
Q1
$238K Buy
3,178
+350
+12% +$26.4K 0.12% 62
2015
Q4
$217K Buy
+2,828
New +$213K 0.11% 65
2015
Q3
– Sell
-2,794
Closed -$207K – 94
2015
Q2
$207K Sell
2,794
-340
-11% -$26K 0.1% 77
2015
Q1
$244K Sell
3,134
-200
-6% -$15.2K 0.11% 72
2014
Q4
$241K Sell
3,334
-460
-12% -$32K 0.22% 64
2014
Q3
$235K Sell
3,794
-500
-12% -$31.8K 0.21% 66
2014
Q2
$274K Sell
4,294
-25
-0.6% -$1.52K 0.22% 59
2014
Q1
$266K Hold
4,319
– – 0.2% 62
2013
Q4
$248K Hold
4,319
– – 0.18% 63
2013
Q3
$230K Sell
4,319
-337
-7% -$18.1K 0.2% 61
2013
Q2
$240K Buy
+4,656
New +$230K 0.2% 57

Other funds holding MDT

Marathon Capital Management's MDT Position: Q3 2026 in Review

Marathon Capital Management increased its Medtronic (MDT) stake by 1.6% in Q3 2026, buying an estimated $15.6K and bringing the position to 11,534 shares worth $995K. The position accounts for 0.2% of the portfolio, ranked #77.

Marathon Capital Management first reported a position in MDT in Q2 2013 and has held it in 15 quarters since. 2,192 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Marathon Capital Management held 11,534 shares of Medtronic worth $995K as of Q3 2026.
  • Marathon Capital Management bought 177 Medtronic shares in Q3 2026, an estimated $15.6K.
  • Medtronic made up 0.2% of Marathon Capital Management's portfolio in Q3 2026, its #77 holding.
  • Marathon Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 15 quarters since.
  • 2,192 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Marathon Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.